|
Obagi Nu-Derm Gets Great Reviews in New Study
Thursday, August 25th, 2011
A recent clinical study published in the July issue of Aesthetic Surgery Journal says that certain patients report much higher rates of satisfaction when using products from the Obagi skin care line.
The study analyzed results of patients who combined their BOTOX treatment with Obagi, versus a control group who used Botox and a placebo. A recent press release specifically reports that Obagi’s Condition and Enhance line “provides greater improvement in overall facial appearance, as well as increased patient satisfaction vs. Botox treatments with a placebo.” The Condition and Enhance line of Obagi products, also marketed as Obagi Nu-Derm, uses a combination of 4 percent hydroquinone and tretinoin.
About the Study
The 120 day study was a multi-center, randomized, investigator-masked, parallel-group study with 61 Botox patients. Patients were randomly prescribed either a hydroquinone system (cleanser, toner, 4% hydroquinone, exfoliant, and sunscreen) combined with 0.05% tretinoin cream, or a “standard skin care regimen” with cleanser, moisturizer, and sunscreen.
Results Found With Obagi
Patients in the Obagi group reported a significant improvement in fine lines, wrinkles and hyperpigmentation. Lead investigator Joel Schlessinger MD said: “This data clearly highlights the fact that by adding Condition & Enhance to injectable patients’ treatment regimen, patients are addressing multiple aspects of aging skin for optimal results.”
Investigators and patients alike were asked to evaluate the results. They found “significantly milder fine lines/wrinkles and hyperpigmentation at days 30, 90, and 120″ in the combination group and patient surveys showed “superior overall ratings.”
Here’s a breakdown of the Obagi results and standard group’s results:
- 89 percent of the combined group was satisfied or extremely satisfied with their results.
- 93 percent of the Obagi group was satisfied or extremely satisfied with the treatment regimen.
- 100 percent of the Obagi Condition and Enhance group wished to continue treatment after the study.
- 12 percent of the “standard skincare group” was satisfied or extremely satisfied with their results and their treatment regimen.
According to ASAPS, “Patients using the hydroquinone system plus tretinoin believed that their study treatment had further enhanced the improvements attained with botulinum toxin type A compared to those using the standard skin care regimen (86% vs. 8%).”
Read more from the following sources:
Sources:
- Obagi Corporate Press Release
- ASAPS: Winning Combination for Botox Patients
- Watch Videos of Obagi Results
Tags: obagi gets good results
Posted in Products | 16 Comments »
Wendy Shares Her Obagi Transformation Story
Wednesday, May 18th, 2011
“I’m aware of what my skin says about my age” and “I have lots of freckles and sun damage” says Wendy, a gregarious 47-year old woman who shares concerns about unwanted changes in her skin texture and complexion.
Wendy is the latest Obagi user to be featured in their “Watch the Transformation” series of videos.
“The Nu-derm has made a big difference in my skin,” she explains. Better skin tone, less visible crow’s feet, minimized fine lines, fewer wrinkles. Most of all, she says she appreciates the fact that she doesn’t need to use makeup anymore.
Tags: obagi
Posted in Products | 5 Comments »
Off-Label Latisse on Good Morning America
Monday, May 9th, 2011
Good Morning America recently aired this story about Latisse being used to treat hair loss. One 27-year old bought and used Latisse on her eyebrows before her wedding. According to ABC News, “some dermatologists have cautiously prescribed it for hair and eyebrow loss that has resisted conventional treatments.”
Since Latisse was FDA approved in 2009, we’ve heard more and more discussion about the drug’s possible application as a hair loss medication.
For now, most people are only considering Latisse for its eyelash-enhancing benefits. Daily application of Latisse can help you grow longer, thicker, darker eyelashes.
Tags: latisse
Posted in In The News, Products | No Comments »
Obagi-Nu Derm Transformed My Skin: Kristen’s Story
Tuesday, April 19th, 2011
“If you just look at my skin – it’s white. It’s just clean all the way through,” exclaims 33-year old Kristen. She’s the first story featured in Obagi’s new “Watch the Transformation” series of videos.
Kristen “tried everything for good skin” but she couldn’t find a practical solution to remove sun spots from her face. She discovered the Obagi Nu-Derm System and experienced a dramatic improvement in her complexion. She tells her story in this YouTube video.
What is the Obagi Nu-Derm system? According to Kristen, it’s a skin care system that quickly removes the dense skin cells on top, and then helps you build new skin cells. With the help of a good doctor, she got set up with a custom-tailored skin care regimen. “My doctor’s really good,” she explains; “she customized it for me , so it’s “Kristen’s Obagi Nu-Derm.”
Tags: obagi nu derm video
Posted in Products | 22 Comments »
Acquisition on the Horizon for Maker of Restylane
Tuesday, December 14th, 2010
Q-Med AB, the Swedish maker of the Restylane family of injectable fillers, recently announced that the company has accepted a conditional acquisition offer from Switzerland-based Galderma SA, for as much as 7.45 billion kronor ($1.08 billion).
Galderma plans to make its offer public in January, and Q-Med’s board has unanimously recommended that its shareholders accept the cash payout offer of 75 kronor a share, which is 13 percent more than Q-Med’s Dec. 10 closing price of 66.25 kronor per share.
All shareholders would purportedly receive this buyout offer with the exception of Q-Med’s founder and Chairman Bengt Aagerup, who would receive 58.94 kronor a share in cash for his 47.5 percent stake in the company.
The one condition of the offer is that Medicis Pharmaceutical Corp., the U.S. company that licenses the Restylane family of injectable fillers and serves as a business partner to Q-Med, must also accept Galderma’s offer, presumably so the Swiss company can achieve its goal of investing in more cosmetic treatment products.
The products that make up the Restylane family of fillers include Restylane, Restylane-L, Perlane and Perlane-L, which have been approved for cosmetic use in Europe since 1996 and in the U.S. since 2003.
Each of these products is derived from hyaluronic acid and used by doctors like New Jersey plastic surgeon Dr. Barry DiBernardo to fill in wrinkles, plump thin lips and restore volume to facial features that have inadequate projection, such as the cheeks and chin.
Nestle SA and L’Oreal SA, the two companies that own Galderma, would each be paying half of the billion-dollar bill to acquire Q-Med, a relatively small amount of the 5 billion Swiss francs ($5.1 billion) that Nestle plans to spend on investments this year.
The acquisition would balance out Galderma’s other cosmetic holdings, such as Cetaphil skin care products and Azzalure, an injectable wrinkle-relaxer similar to Botox approved for use outside the U.S.
Tags: botox, injectable fillers, restylane, skin care, skin rejuvenation
Posted in Botox, In The News, Injectable Fillers, Products | 3 Comments »
Product Feature: Obagi ELASTILash
Tuesday, November 30th, 2010
Obagi recently announced the arrival of ELASTILash, an eyelash solution they say can help you achieve the appearance of thicker, fuller lashes without a prescription.
Known for their high quality medical grade skincare products, Obagi is obviously taking aim at the growing market for Latisse, the popular prescription eyelash solution by Allergan Inc.
Instead of the growth-inducing bimatoprost contained in Latisse, ELASTILash works with a peptide-based solution. The new product is hypoallergenic, physician tested and according to an official press release, 70 percent of patients in clinical trials reported the appearance of thicker, fuller lashes in 4-6 weeks.
ELASTILash is applied with “one generous brush stroke along the entire upper eyelash line every night.” The product is supposed to be available in physician’s offices soon at a price around $60 each.
Contact New Jersey Plastic Surgery for information on Obagi products
Tags: ELASTIlash
Posted in Products | 12 Comments »
What Women Want from Skin Care and Cosmetics: New Survey
Sunday, October 3rd, 2010
Last month, Harris Interactive and Neutrogena conducted an online survey that “explores the complex relationship women have with their cosmetics.” 1,018 women over the age of 18 responded to the survey, answering questions about their priorities and needs when it comes to skin care and cosmetics.
Women’s Skincare Needs, Quantified
- 58 % said if they could own one product, it should be one that delivers flawless skin tone.
- 68 % would give up something important to have flawless skin
- 46 % say they’ve incorporated makeup into their skincare routine
- 56 % are relying on cosmetics that offer sun protection
- 58 % women over age 55 want to minimize lines and wrinkles
- 8 % want longer eyelashes
- 3 % want fuller lips
- 2 % want enhanced cheekbone definition
Read more about these survey results on JNJ.com
Maintaining Healthy Skin
Great products are a key factor in maintaining beautiful, healthy skin, but many people also need professional guidance from a physician or aesthetician – especially those who have sensitive or dry skin. If you’re one of the many patients regularly undergoing procedures like microdermabrasion or a chemical peel, you’ll definitely benefit from a physician’s guidance in choosing skincare products that work in conjunction with your treatment.
Click here to read more about using medical grade skin care products as part of an effective cosmetics routine.
Tags: cosmetics, skin care
Posted in Products | 11 Comments »
Featured Product: Obagi ELASTIderm Eye Treatment
Friday, September 3rd, 2010
If you’re bothered by fine lines and wrinkles around your eyes (and who doesn’t have a few?) then you may want to check out this medical grade product from Obagi Medical. The ELASTIderm eye treatment is designed to restore elasticity in your skin and reduce those persistent lines near the eyes.
What’s Inside?
Obagi’s trademarked Penetrating Therapeutics deliver ingredients like zinc, copper, malonic acid and blueberry extract.
How do I use it?
ELASTIderm eye cream is designed to be applied to the skin of both corners around the eyes as well as the eyelids. After cleansing, toning and application of prescription skincare products, apply the eye cream and then follow with moisturizer and sun protection.
Read more about Obagi ELASTIderm at New Jersey Plastic Surgery
Tags: eye cream, obagi
Posted in Products | 20 Comments »
